129
129
369
369
452
452
2019
2017
University (950)
1 - 10 of 950
Sort by
Opportunity
IDFBX2:4398Post Date2019-10-30
Dr. Morrissey's lab makes carefully size-fractionated preparations of inorganic polyphosphate that are useful to researchers working to understand the biological functions of this polymer. The lab also makes modified forms of polyphosphate in which organic molecules such as biotin are covalently attached to the terminal phosphates of polyphosphate, typically by phosphoramidate linkages. Many of these polyphosphate preparations are not commercially available.
Opportunity
IDFBX2:4383Post Date2019-10-29
Allows for the detection of Polyphosphate (polyP) in both environmental and clinical samples using a simplified ELISA based assay. This will allow for better purification of sewage and waste water as well as more targeted anticoagulant therapies for patients.
Opportunity
IDFBX2:4325Post Date2019-10-28
This package contains installers for two programs that perform single-molecule kinetic fingerprinting (SiMREPS=single-molecule recognition through equilibrium Poisson sampling) analysis using one or more grayscale TIF stacks (movies) as input. The first program generates intensity-versus-time traces form grayscale TIF stacks for subsequent kinetic analysis. The second program performs kinetic analysis of the intensity-versus-time traces to determine whether each trace corresponds to nonspecif…
Opportunity
Track Code17-1403Post Date2019-10-23TypeAvailable Technology
TTO Home Page: http://wayne.technologypublisher.com Name : Ken Massey
Opportunity
Track Code4264Post Date2019-10-17TypeAvailable Technology
Malformed ears are exceptionally difficult to reconstruct due to their complex geometry, yet they are important to treat early because they can cause improper hearing and may lead to psychosocial harm and low self-esteem. Unfortunately, current treatment approaches are lacking. One approach involves using rib cartilage of the patient to reconstruct the ear, which requires a large amount of cartilage that can only be acquired from a patient at least 8 years in age. This process can be painf…
Opportunity
Track Code4279Post Date2019-10-17TypeAvailable Technology
Immunotherapy has shown promising results in the treatment of certain advanced cancers. It is fast becoming an attractive alternative to current anti-cancer treatments. Specifically, the recent development of adoptive cell transfer immunotherapies using T-cells are being tested widely in animal models and cancer patients. While these therapies have solely focused on T-cells, a novel technology involving both effector T and B-cells was found to significantly improve treatment outcomes in an…
Opportunity
Track Code4271Post Date2019-10-17TypeAvailable Technology
Summary: This invention involves the synthesis, use, and pharmaceutical composition/carrier of a series of novel anthranilic diamide derivatives that were cytotoxic to a series of cancer cell lines and effectively treated a xenograft model of pancreatic cancer. These compounds were also effective in modulating several signaling pathways and DNA repair. Applications: Treatment for cancer Treatment for pancreatic cancer Advantages: There are no other effective treatments available for pancrea…
Opportunity
Track Code3984Post Date2019-10-17TypeAvailable Technology
Oxytocin-Ires Cre mice These mice express Cre recombinase under the control of the oxytocin promoter and are an effective tool for specifically targeting oxytocin neurons. Wu Z; Xu Y; Zhu Y; Sutton AK; Zhao R; Lowell BB; Olson DP; Tong Q. 2012. An obligate role of oxytocin neurons in diet induced energy expenditure. PLoS One 7(9):e45167 PubMed: 23028821,
Opportunity
Track Code3985Post Date2019-10-17TypeAvailable Technology
F5 knock-outmice TheseF5knock-out mice exhibit factor V deficiency resulting in neonatal massive intra-abdominal hemorrhage and death. Cui J; O'Shea KS; Purkayastha A; Saunders TL; Ginsburg D. 1996. Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 384(6604):66-8 PubMed: 8900278,